Niche pharma consulting Small, women-owned health care consulting firm focused on pharmaceutical data services and Medicaid/public sector clients presents a target for tailored, high-touch outreach to health plans, academic institutions, and industry associations seeking specialized pharmacoeconomic and outcome analyses.

Upsell data expertise Proven capabilities in data analysis, predictive modeling, and claims data analysis can be positioned to expand current services into broader population health management, medication therapy management optimization, and pharmacy benefit management policy support for clients looking to improve outcomes and reduce costs.

Technology footprint Leveraging Joomla, MooTools, jQuery, PHP and analytics tooling, SEC can be pitched as agile, cost-effective partner for quick-turn calculations and custom analyses, appealing to smaller plans and institutions needing impactful insights without large enterprise overhead.

Growth through collaboration With a lean team and national reach, SEC can pursue partnerships or subcontracting opportunities with large consulting firms and CROs (e.g., for Medicaid and government programs) to scale delivery while maintaining specialized expertise in pharmacoeconomics and utilization review.

Revenue growth paths Current revenue under one million signals room to expand by expanding service lines (reimbursement policy compliance, auditing, utilization review) and targeting mid-market health plans and academic entities that seek cost-effective, data-driven decision support.